|
Match
|
Document |
Document Title |
|
|
8153623 |
Compounds
Compounds of formula (I), pharmaceutical compositions thereof, and methods for treatment using the same.
|
|
|
8143193 |
Active agents combination exhibiting insecticidal and acaricide properties
The novel active compound combinations of cyclic ketoenols of the formula (I) and the active compounds of the formula (II) listed in the description have very good insecticidal and acaricidal...
|
|
|
8138119 |
Alkoxyalkyl spirocyclic tetramic acids and tetronic acids
The invention relates to novel alkoxyalkyl spirocyclic tetramic and tetronic acids of the formula (I), in whichA, B, D, Q1, Q2, Q3, Q4, G, W, X, Y and Z are as defined above,to a plurality of...
|
|
|
8105979 |
Active ingredient combinations with insecticidal and acaricidal properties
The present invention relates to novel active compound combinations comprising at least one known compound from the class of the tetronic or tetramic acids and at least one further known active...
|
|
|
8106087 |
Spiro-oxindole compounds and their uses as therapeutic agents
This invention is directed to spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer...
|
|
|
8088815 |
Spiroindolinone pyrrolidines
There are provided compounds of the formula wherein X, Y and R1 to R8 are described herein along with the enantiomers, pharmaceutically acceptable salts and esters thereof. The compounds are useful...
|
|
|
8058288 |
Amido compounds and their use as pharmaceuticals
The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The ...
|
|
|
8044085 |
Active agent combinations with insecticidal and acaricidal properties
The invention relates to novel active compound combinations of certain having very good insecticidal and acaricidal properties and containing (a) cyclic ketoenols having the formula in which the...
|
|
|
8039503 |
Lapachone compounds and methods of use thereof
The present invention provides novel tricyclic spiro-oxathiine naphthoquinone derivatives, a synthetic method for making the derivatives, and the use of the derivatives to induce cell death and/or...
|
|
|
7998959 |
Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1 and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of ...
|
|
|
7994208 |
Crystalline chemotherapeutic
N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methy
lphenyl)urea·¼ Ethanolate Crystalline Form 1, ways to make it, formulations comprising it and made with it and methods of treating pat...
|
|
|
7968585 |
Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
The present invention discloses novel compounds of Formula (I): having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention ...
|
|
|
7968107 |
Oil-based suspension concentrates
New, oil-based suspension concentrates composed of at least one room-temperature-solid active agrochemical substance,at least one “closed” penetrant,at least one vegetable oil or mineral oil,at lea...
|
|
|
7960404 |
Spirocyclic cyclohexane compounds
Spirocyclic cyclohexane compounds corresponding to formula I in which R1 and R2 form a pyrrolidine ring or an azetidine ring and which exhibit increased metabolic stability, a process for producing...
|
|
|
7947704 |
2,4,6-phenyl-substituted cyclic ketoenols
The invention relates to novel 2,4,6-phenyl-substituted cyclic ketoenols of the formula (I), in which CKE, W, X and Y are as defined above,to a plurality of processes and intermediates for their...
|
|
|
7943605 |
Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
The present invention relates to compounds of formula (I) comprising a lactam or a lactam derivative moiety, processes for preparing them, pharmaceutical compositions comprising said compounds and...
|
|
|
7935721 |
Spiro-oxindole compounds and their uses as therapeutic agents
This invention is directed to spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer...
|
|
|
7915282 |
C2-phenyl-substituted cyclic keto-enols used as pesticides and herbicides
The present invention relates to novel C2-phenyl-substituted cyclic ketoenols of the formula (I) in which W, X, Y, Z and CKE are as defined in the description, to processes for their preparation...
|
|
|
7829535 |
Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway
Methods for promoting osteogenesis to accelerate or enhance bone fracture healing, treat bone defects, and enhance bone formation are disclosed. The methods modulate an arachidonic acid metabolic...
|
|
|
7825152 |
Organic compounds and their uses
The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
|
|
|
7803833 |
Compounds
The invention relates to quaternary α-aminocarboxyamide derivatives of formula (I), wherein R1, R2, R3, R4, R5, R6, X, q and n are as defined in claim 1, for treating diseases and conditions ...
|
|
|
7781449 |
Trospium chloride treatment method
A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum...
|
|
|
7781448 |
Once daily dosage forms of trospium
A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum...
|
|
|
7776874 |
Amido compounds and their use as pharmaceuticals
The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The ...
|
|
|
7763635 |
Once daily dosage forms of trospium
A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum...
|
|
|
7759359 |
Method of treating bladder dysfunction with once-a-day trospium salt formulation
A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum...
|
|
|
7759383 |
Small molecule inhibitors of MDM2 and the uses thereof
The invention relates to small molecules which function as inhibitors of the interaction between p53 and MDM2. The invention also relates to the use of these compounds for inhibiting cell growth,...
|
|
|
7727933 |
2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives
The invention relates to novel 2-ethyl-4,6-dimethylphenyl-substituted spirocyclic tetramic acid derivatives of the formula (I) in which A, B and G are as defined above, to a plurality of processes...
|
|
|
7723372 |
Spiroindolinone derivatives
There are provided compounds of the general formulas wherein W, X, Y, R1, R2, R3, and R4 are as described herein. The compounds exhibit anticancer activity.
|
|
|
7700641 |
Spiro-oxindole compounds and their uses as therapeutic agents
This invention is directed to spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer...
|
|
|
7659300 |
Monocyclic anilide spirolactam CGRP receptor antagonists
The present invention is directed to compounds of Formula I: I (where A1, A2, B, J, K, m, n, R4, R5a, R5b and R5c are as defined herein) useful as antagonists of CGRP receptors and useful in the...
|
|
|
7655686 |
Certain substituted spirocyclic lactams and use thereof as pharmaceuticals
The present invention relates to novel 2-(6-oxo-1,7-diaza-spiro[4.4]non-7-yl)-propionamides of the formula wherein R1, R2, R3, R4, R5, R6, m and p are as defined in the specification, to their...
|
|
|
7638547 |
Cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives serving as pesticides
The invention relates to novel cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives of the formula (I) in which A, G, X and Y are as defined in the disclosure, to a plurality of...
|
|
|
7638548 |
Spiroindolinone derivatives
There are provided compounds of the general formulas wherein X, Y, R1, R2, R3 and R4 are as described herein. The compounds exhibit anticancer activity.
|
|
|
7550499 |
Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
The present invention provides novel ureas containing N-aryl or N-heteroaryl substituted heterocycles and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention...
|
|
|
7538135 |
Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
Compounds of the formula provide pharmacological agents which bind to Peroxisome Proliferator-Activated Receptors (PPARs). Accordingly, the compounds of the instant invention are useful for the...
|
|
|
7528156 |
Compounds
The invention provides compounds of general formula (D wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7, and R8 are as defined in the specification, processes for their preparation,...
|
|
|
7524856 |
Tricyclic spiroderivatives as modulators of chemokine receptor activity
The invention provides compounds of formula (I) wherein m, R1, n, R2, q, p, X, Y, R3, R4, t and, R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions...
|
|
|
7514466 |
Purification of progesterone receptor modulators
Methods for purifying a compound of formula I are provided, wherein A, B X, Q, and R1 are defined herein. The methods include mixing the compound of formula I and a solvent; adding a base to the...
|
|
|
7498338 |
Compounds
The invention provides compounds of formula (I) wherein m, R1, n, R2, q, X, Y, Z, t, R3, R4, R5, R6, R7 and R8 are as defined in the specification, processes for their preparation, pharmaceutical...
|
|
|
7476688 |
Cyclic amidine derivatives
A cyclic amidine derivative represented by the formula: [wherein R1, R2 and R3 represent hydrogen, C1-6 alkyl, aryl-C1-6 alkyl, etc.; R4, R5 and R7 represent hydrogen, C1-6 alkyl, etc.; Z...
|
|
|
7449475 |
Tricyclic spiropiperidines or spiropyrrolidines
The invention provides compounds of formula (I) wherein m R1, n, R2, q, X, Y, Z, R3, R4, R5, R6, R7, R8, t, and R9 are as defined in the specification, processes for their preparation,...
|
|
|
7439263 |
Pyrrolidine and thiazolidine compounds
Compounds of formula (I): wherein: X1 represents an atom or group selected from CR4aR4b, O, S(O)q1 and NR5, wherein R4a, R4b, q1 and R5 are as defined in the description,m1 represents zero or an...
|
|
|
7410978 |
Once daily dosage forms of trospium
A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum...
|
|
|
7396846 |
Growth hormone secretagogues
This invention relates to novel compounds which are useful in the modulation of endogenous growth hormone levels in a mammal. The invention further relates to novel intermediates for use in the...
|
|
|
7393858 |
Tetrahydropyran compounds as tachykinin antagonists
The present invention relates to compounds of formula (Ia) wherein A, B, n, m, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 are defined herein, and pharmaceutically acceptable salts thereof; the...
|
|
|
7390798 |
Carboxamide spirolactam CGRP receptor antagonists
The present invention is directed to compounds of Formula I: I (where variables A1, A2, B, J, K, m, n, R4, R5a, R5b and R5c are as defined herein) useful as antagonists of CGRP receptors and useful...
|
|
|
7304081 |
Amido compounds and their use as pharmaceuticals
The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The ...
|
|
|
7288560 |
Spirocyclic cyclohexane derivatives
The present invention relates to spirocyclic cyclohexane compounds, to methods for their production, to pharmaceutical compositions containing these compounds, to methods of treatment using such...
|
|
|
7250438 |
Anti-bacterial and anti-cancer spiro beta-lactone/gamma-lactams
Disclosed herein are novel spiro beta-lactone/gamma lactams for use in treating bacterial infections and cancer. The compounds are characterized by a terminal electron-withdrawing group such as a...
|